MY155313A - Variant activin receptor polypeptides and uses thereof - Google Patents
Variant activin receptor polypeptides and uses thereofInfo
- Publication number
- MY155313A MY155313A MYPI20093636A MYPI20093636A MY155313A MY 155313 A MY155313 A MY 155313A MY PI20093636 A MYPI20093636 A MY PI20093636A MY PI20093636 A MYPI20093636 A MY PI20093636A MY 155313 A MY155313 A MY 155313A
- Authority
- MY
- Malaysia
- Prior art keywords
- receptor polypeptides
- variant
- activin receptor
- variant activin
- present
- Prior art date
Links
- 102000018918 Activin Receptors Human genes 0.000 title 1
- 108010052946 Activin Receptors Proteins 0.000 title 1
- 108010059616 Activins Proteins 0.000 abstract 2
- 102100026818 Inhibin beta E chain Human genes 0.000 abstract 2
- 239000000488 activin Substances 0.000 abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 102100040898 Growth/differentiation factor 11 Human genes 0.000 abstract 1
- 101710194452 Growth/differentiation factor 11 Proteins 0.000 abstract 1
- 102100039939 Growth/differentiation factor 8 Human genes 0.000 abstract 1
- 206010028289 Muscle atrophy Diseases 0.000 abstract 1
- 108010056852 Myostatin Proteins 0.000 abstract 1
- 208000037765 diseases and disorders Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 201000000585 muscular atrophy Diseases 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
THE PRESENT INVENTION PROVIDES VARIANT ACTIVIN IIB SOLUBLE RECEPTOR POLYPEPTIDES AND PROTEINS CAPABLE OF BINDING AND INHIBITING THE ACTIVITIES OF ACTIVIN A, MYOSTATIN, OR GDF-11. THE PRESENT INVENTION ALSO PROVIDES POLYNUCLEOTIDES, VECTORS AND HOST CELLS CAPABLE OF PRODUCING THE VARIANT POLYPEPTIDES AND PROTEINS. COMPOSITIONS AND METHODS FOR TREATING MUSCLE-WASTING AND OTHER DISEASES AND DISORDERS ARE ALSO PROVIDED.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US90545907P | 2007-03-06 | 2007-03-06 | |
| US6574708P | 2008-02-11 | 2008-02-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY155313A true MY155313A (en) | 2015-09-30 |
Family
ID=54779992
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI20093636A MY155313A (en) | 2007-03-06 | 2008-03-06 | Variant activin receptor polypeptides and uses thereof |
Country Status (1)
| Country | Link |
|---|---|
| MY (1) | MY155313A (en) |
-
2008
- 2008-03-06 MY MYPI20093636A patent/MY155313A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12013502308A1 (en) | Variant activin receptor polypeptides and uses thereof | |
| TN2011000238A1 (en) | Variants of activin iib receptor polypeptides and uses thereof | |
| HK1203384A1 (en) | Variant activin receptor polypeptides, alone or in combination with chemotherapy, and uses thereof | |
| ATE554101T1 (en) | NEW ACTIVIN RECEPTOR AND APPLICATIONS THEREOF | |
| WO2008121767A3 (en) | Stitched polypeptides | |
| WO2009012176A3 (en) | Methods and compositions for treating brain diseases | |
| WO2008088583A3 (en) | Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer | |
| MX2009008222A (en) | Activin-actriia antagonists and uses for treating or preventing breast cancer. | |
| WO2010009368A3 (en) | Compositions for the detection and treatment of colorectal cancer | |
| WO2008021851A3 (en) | Novel compounds as antagonists or inverse agonists for opioid receptors | |
| AU2010226726A8 (en) | Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities | |
| WO2007022273A3 (en) | Vegf-activated fas ligands | |
| WO2009071689A3 (en) | 5-halogen-substituted oxindole derivatives and use thereof for treating vasopressine-dependent diseases | |
| WO2008112290A3 (en) | Use of ephb4 as a diagnostic marker and a therapeutic target for ovarian cancer | |
| WO2010132370A8 (en) | Soluble trem-1 family peptides and methods of use | |
| GB0524477D0 (en) | Isolated T cell receptors which specifically bind to vygfvracl-hla-24 | |
| AU2018278809A1 (en) | Recombinant ROBO2 proteins, compositions, methods and uses thereof | |
| WO2008103966A3 (en) | Compositions and methods using toll-like receptors and unc93b | |
| MY155313A (en) | Variant activin receptor polypeptides and uses thereof | |
| WO2006002854A3 (en) | Tie receptor and tie ligand materials and methods for modulating female fertility | |
| MX2009009178A (en) | Bazedoxifene bis-phosphorates. | |
| TW200602055A (en) | Spray dried pharmaceutical compositions | |
| TW200621265A (en) | Composition for treating tumor and/or preventing tumor transfer and recurrence |